New therapy aims to help kids with speech disorder speak in phrases

NCT ID NCT07526246

Not yet recruiting Symptom relief Sponsor: New York University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 4 times

Summary

This study tests a speech therapy called DTTC-Connect for children aged 3 to 12 with childhood apraxia of speech, a disorder that makes it hard to say words clearly. The therapy focuses on helping children move from saying single words to speaking in phrases. Sixty-eight children will receive the therapy twice a week for 8 weeks, and researchers will measure improvements in phrase accuracy and how well others understand them.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dynamic Temporal and Tactile Cueing-Connect (DTTC-Connect) behavioral therapy
What this could lead to: If successful, this therapy could help children with apraxia of speech speak more clearly in phrases and sentences, improving their daily communication.
What could go wrong: This is a Phase II trial with only 68 participants, so results may not apply to all children. The therapy is intensive (16 sessions) and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDHOOD APRAXIA OF SPEECH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

apraxia childhood apraxia of speech

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILDHOOD APRAXIA OF SPEECH

More trials for these conditions

Other studies related to the condition(s) this trial covers.